1. Home
  2. MDAI vs BDSX Comparison

MDAI vs BDSX Comparison

Compare MDAI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • BDSX
  • Stock Information
  • Founded
  • MDAI 2013
  • BDSX 2005
  • Country
  • MDAI United States
  • BDSX United States
  • Employees
  • MDAI N/A
  • BDSX N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • BDSX Precision Instruments
  • Sector
  • MDAI Health Care
  • BDSX Health Care
  • Exchange
  • MDAI Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • MDAI 51.9M
  • BDSX 53.0M
  • IPO Year
  • MDAI N/A
  • BDSX 2020
  • Fundamental
  • Price
  • MDAI $2.13
  • BDSX $6.83
  • Analyst Decision
  • MDAI Strong Buy
  • BDSX Strong Buy
  • Analyst Count
  • MDAI 1
  • BDSX 5
  • Target Price
  • MDAI $3.50
  • BDSX $32.50
  • AVG Volume (30 Days)
  • MDAI 868.8K
  • BDSX 280.7K
  • Earning Date
  • MDAI 11-11-2025
  • BDSX 11-03-2025
  • Dividend Yield
  • MDAI N/A
  • BDSX N/A
  • EPS Growth
  • MDAI N/A
  • BDSX N/A
  • EPS
  • MDAI N/A
  • BDSX N/A
  • Revenue
  • MDAI $27,549,000.00
  • BDSX $76,556,000.00
  • Revenue This Year
  • MDAI N/A
  • BDSX $18.78
  • Revenue Next Year
  • MDAI $60.05
  • BDSX $26.42
  • P/E Ratio
  • MDAI N/A
  • BDSX N/A
  • Revenue Growth
  • MDAI 22.27
  • BDSX 25.70
  • 52 Week Low
  • MDAI $1.01
  • BDSX $3.44
  • 52 Week High
  • MDAI $3.25
  • BDSX $34.39
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 44.61
  • BDSX 54.95
  • Support Level
  • MDAI $2.07
  • BDSX $6.22
  • Resistance Level
  • MDAI $2.27
  • BDSX $7.00
  • Average True Range (ATR)
  • MDAI 0.19
  • BDSX 0.66
  • MACD
  • MDAI -0.04
  • BDSX -0.19
  • Stochastic Oscillator
  • MDAI 7.61
  • BDSX 50.36

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: